Condition: Recurrent Atrial Fibrillation · Persistent Atrial Fibrillation · Sponsor: University Hospital Ostrava
A study comparing atrioventricular junction ablation (AVJA) versus continued optimum medical rate control in patients with cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) with suboptimal heart rate control on optimum medication.
This description comes directly from the study's public registry record.
Jiří Hynčica · 0042059737 · jiri.hyncica@fno.cz
Always discuss trial participation with your own doctor first.
| Regional Hospital Liberec | Liberec, Liberec Region, Czechia | Recruiting |
| University Hospital Ostrava | Ostrava, Moravian-Silesian Region, Czechia | Recruiting |
| Hospital Podlesí, Inc. | Třinec, Moravian-Silesian Region, Czechia | Recruiting |
| University Hospital Olomouc | Olomouc, Olomouc Region, Czechia | Recruiting |
| Hospital České Budějovice | České Budějovice, South Bohemian Region, Czechia | Recruiting |
| St. Anne's University Hospital Brno | Brno, South Moravian, Czechia | Recruiting |
| University Hospital Brno | Brno, South Moravian, Czechia | Recruiting |
| Institute of Clinical and Experimental Medicine | Prague, Czechia | Recruiting |
| Military University Hospital Prague | Prague, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05776797